These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2319996)

  • 21. Successful use of high dose intravenous immunoglobulin in rapidly progressive crescentic glomerulonephritis with vasculitis.
    Basok A; Shnaider A; Tovbin D; Rogachev B
    Isr Med Assoc J; 2001 Jun; 3(6):453-4. PubMed ID: 11433643
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombocytopenia in a patient with hemophilia and HIV infection treated with intravenous immunoglobulin and splenectomy].
    Rozmysłowicz T; Ziemski JM; Rudowski W; Lopaciuk S
    Przegl Dermatol; 1989; 76(4):302-7. PubMed ID: 2517146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reactions following administration of preparations of normal human immunoglobulins (gamma globulin)].
    Galazka A
    Przegl Epidemiol; 1971; 25(1):111-7. PubMed ID: 5088682
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on immune serum globulin (IgG) and its modification for intravenous administration.
    Sgouris JT
    Prog Immunobiol Stand; 1970; 4():104-13. PubMed ID: 4249358
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates.
    Christensen RD; Hardman T; Thornton J; Hill HR
    J Perinatol; 1989 Jun; 9(2):126-30. PubMed ID: 2738720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of high doses of intravenous immunoglobulin in the treatment of neonatal thrombocytopenia secondary to maternal idiopathic thrombopenic purpura].
    García-Monge Santidrian S; Hawkins Carranza F; Arroyo Carrera I; Muro Brussi M; Sacristán Martín A; Cabañas González F; Escribá Polo R; Magallón Martínez M; Quero Jiménez J
    An Esp Pediatr; 1988 Oct; 29(4):333-4. PubMed ID: 3232883
    [No Abstract]   [Full Text] [Related]  

  • 27. High-dose intravenous therapy with immune globulin before delivery for idiopathic thrombocytopenic purpura.
    Adderley RJ; Rogers PC; Shaw D; Wadsworth LD
    Can Med Assoc J; 1984 Apr; 130(7):894-6. PubMed ID: 6423252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Replacement therapy with intravenous gamimune serum].
    Golan D; Tubi E
    Harefuah; 1986 Apr; 110(8):411-3. PubMed ID: 3091460
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
    Norrby-Teglund A; Haque KN; Hammarström L
    J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of immunoglobulins in pediatrics].
    Fischer A
    Arch Fr Pediatr; 1988 Dec; 45(10):779-81. PubMed ID: 3071284
    [No Abstract]   [Full Text] [Related]  

  • 31. Dosage of intravenously administered immune globulin and dosing interval required to maintain target levels of immunoglobulin G in low birth weight infants.
    Kyllonen KS; Clapp DW; Kliegman RM; Baley JE; Shenker N; Fanaroff AA; Berger M
    J Pediatr; 1989 Dec; 115(6):1013-6. PubMed ID: 2511290
    [No Abstract]   [Full Text] [Related]  

  • 32. [Idiopathic thrombocytopenic purpura and nephrotic syndrome in pregnancy. Results of treatment with intravenous immunoglobulins].
    Spinozzi F
    Medicina (Firenze); 1988; 8(1):60-1. PubMed ID: 3226248
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of a new, low-pH immunoglobulin G preparation during episodes of bacteremia in the rat.
    Emerson TE; Collins MS; Budinger MD
    Rev Infect Dis; 1986; 8 Suppl 4():S409-19. PubMed ID: 3092308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties and characteristics of a new immunoglobulin G intravenous preparation. A symposium. Chicago, Illinois, June 7, 1985.
    Rev Infect Dis; 1986; 8 Suppl 4():S371-463. PubMed ID: 3092302
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early immunoglobulin therapy in high risk patients for infection after heart surgery].
    Pilz G; Kreuzer E; Kääb S; Appel R; Werdan K
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():35-40; discussion 41. PubMed ID: 8499749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous therapy with gamma globulin.
    Dwyer JM
    Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human IgA- and IgM-globulins for clinical use.
    Schwick HG; Fischer J; Geiger H
    Prog Immunobiol Stand; 1970; 4():86-91. PubMed ID: 4991598
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficaciousness of immunoglobulin G prophylaxis on mortality and physiological variables in gram-negative peritonitis in rodents.
    Emerson TE; Lurton JM; Collins MS
    Circ Shock; 1985; 17(3):213-22. PubMed ID: 3907885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Considerations in the use of intravenous immune globulin products.
    Clin Pharm; 1990 Dec; 9(12):909, 912. PubMed ID: 2292173
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in intravenous immunoglobulin therapy. A symposium held in conjunction with the 15th International Cancer Congress. Hamburg, Germany, August 1990.
    Cancer; 1991 Sep; 68(6 Suppl):1415-64. PubMed ID: 1878839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.